Skip to main content
. 2016 Dec 15;8(7):11400–11413. doi: 10.18632/oncotarget.13940

Table 1. Patient characteristics.

miR-17-5p Study(n = 18) Gene Target Study(n = 30)
Male 16 25
Female 2 5
Age (years)a 63 (37-75) 61 (37-75)
Clinical TNM Stage
 I 0 1
 IIa 6 8
 IIb 2 4
 III 10 17
 IV 0 0
TRG
 1 3 5
 2 5 6
 3 0 9
 4 8 8
 5 2 2

Abbreviations: aValues given are mean (range); TNM, Tumor-node-metastasis clinical staging classification; TRG, Tumour regression grade.